Macías-Parra M, Rojas-Maruri M, Ridaura-Sanz C

Language: Spanish
References: 23
Page: 402-410
PDF size: 856.88 Kb.

ABSTRACT

No abstract.

REFERENCES

1. Ganzel C, Becker J, Mintz PD, Lazaruz HM, Rowe JM. Hyperleukocytosis, leukostasis and leukapheresis: Practice management. Blood Reviews 2012;26(3):117-122.

2. Janka GE & Lehmberg K. Hemophagocytic syndromes – An update. Blood reviews 2014;28:135-142.

3. Chandrakasan S, Filipovich AH. Hemophagocytic Lymphohistiocytosis: Advances in Pathophysiology, Diagnosis and Treatment. The Journal of Pediatrics 2013;163(5):1253- 1259.

4. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48(2):124-31.

5. Kaplan SL, Mason Jr EO, Barson WJ, Wald ER, Arditi M, Tan TQ, et al. Three-Year Multicenter Surveillance of Systemic Pneumococcal Infections in Children. Pediatrics 1998;102(3):538–45.

6. Constantinescu AR, Bitzan M, Weiss LS, Christen E, Kaplan BS, Cnaan A, et al. Non-enteropathic hemolytic uremic syndrome: causes and short-term course. Am J Kidney Dis 2004;43(6):976–82.

7. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009;361(17):1676–87.

8. Copelovitch L, Kaplan BS. Streptococcus pneumoniaeassociated hemolytic uremic syndrome. Pediatr Nephrol 2008;23(11):1951–6.

9. Calbo E, et al. Invasive pneumococcal disease. Clinical Infectious Diseases 2005;41:1821-1822.

10. Tinsa F, et al. Pneumococcal infection and hemolytic uremic syndrome. Tunis Med 2009;87(11):790-2.

11. Oliver JW, et al. Pneumococcal Induced T Activation With Resultant Thrombotic Microangiopathy. Clinical Med Insights Pathology 2010;3:13-17.

12. D.-Byington CL, et al. Impact of the Pneumococcal. Pediatric Infection Diseases J 2006;25:250-254.

13. Canadian Paediatric Society; Health Canada. Canadian Paediatric Surveillance Program: 2002 Results. Ottawa, Ontario, Canada: Canadian Paediatric Society; 2003:27–28.

14. Brandt J, Wong C, Mihm S, Roberts J, Smith J, Brewer E, et al. Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics 2002;110(2 Pt 1):371–6.

15. Lee C-S, Chen M-J, Chiou Y-H, Shen C-F, Wu C-Y, Chiou Y-Y. Invasive pneumococcal pneumonia is the major cause of paediatric haemolytic-uraemic syndrome in Taiwan. Nephrology (Carlton) 2012;17(1):48–52.

16. Copelovitch L, Kaplan BS. Streptococcus pneumoniae--associated hemolytic uremic syndrome: classification and the emergence of serotype 19A. Pediatrics 2010;125(1):e174–82.

17. Veesenmeyer AF, Edmonson MB. Trends in US hospital stays for Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Infect Dis J 2013;32(7):731–5.

18. Coats MT, Murphy T, Paton JC, Gray B, Briles DE. Exposure of thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase. Microb Pathog 2012;50(6):343–9.

19. Ramasethu J, Luban n. t activation. Br J Haematol 2001;112:259–263.

20. Cochran JB, Panzarino VM, Maes LY, Tecklenburg FW. Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol 2004;19(3):317–21.

21. Parker D, Soong G, Planet P, Brower J, Ratner AJ, Prince A. The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect Immun 2009;77(9):3722–30.

22. Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, et al. Pneumococcal Necrotizing Pneumonia in Utah: Does Serotype Matter? 2013;46:1346–52.

23. Echániz- Gaviléz G, San Román Álvarez L, Sánchez- Alemán M, Carnalla- Barajas MN, Soto Nogueron. Prevalencia de Streptococcus pneumoniae serotipo 19A antes y después de la introducción de la vacuna heptavalente en México. Salud Pub de México 2014;56(3):266-271.